External reports (aggregated public sources), Value Investors Club

Value Investors Club

External reports (aggregated public sources)

Equity Bottom-Up

Key points (machine generated)<ul><li>A case involving Ambase is expected to go to trial or be resolved through summary judgment in early 2025.</li><li>The outcome of this litigation will have a significant impact on the potential value of Ambase as an investment, as its current market cap is significantly below the potential claim.</li><li>The upcoming document discovery process and motions for summary judgment will allow investors to evaluate the chances of a positive outcome and potential net recovery for Ambase shareholders.</li></ul>This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Key points (machine generated)A case involving Ambase is expected to go to trial or be resolved through summary judgment in early 2025.The outcome of this litigation will have a significant impact on the potential value of Ambase as an investment, as its current market cap is significantly below the potential claim.The upcoming document discovery process and motions for summary judgment will allow investors to evaluate the chances of a positive outcome and potential net recovery for Ambase shareholders.This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Ambase Corp (ABCP) - Friday, Oct 27, 2023

Event-Driven Investment Opportunities, Special Situation Investments

Dalius Tauraitis

Event-Driven Investment Opportunities

Special Situation Investments

Focus on event-driven trades and low risk arbitrage opportunities with short term catalysts

Event-Driven

<ul><li>VIZIO faces antitrust concerns with Walmart acquisition; FTC scrutiny and potential challenges could impact deal closure and stock price.</li><li>Microstrategy trades at a 200%+ NAV premium, historically unsustainable, with potential for reversion amid hedging opportunities.</li><li>Liquidia's drug commercialization delayed by competitor's legal actions; tentative FDA approval secured, pending exclusivity expiration in May 2025.</li></ul>

VIZIO faces antitrust concerns with Walmart acquisition; FTC scrutiny and potential challenges could impact deal closure and stock price.Microstrategy trades at a 200%+ NAV premium, historically unsustainable, with potential for reversion amid hedging opportunities.Liquidia's drug commercialization delayed by competitor's legal actions; tentative FDA approval secured, pending exclusivity expiration in May 2025.

Analyzing Active Portfolio Ideas: Antitrust, Asset Sales, Arbitrage, and Litigation Opportunities

United States

AmBase Corporation owns and operates multiple real estate properties. The Company, through their subsidiaries, provides services in the management, operation, ownership, and lease of commercial office buildings.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

AmBase (ABCP US)

Ambase Corp (ABCP) - Friday, Oct 27, 2023

The outcome of this litigation will have a significant impact on the potential value of Ambase as an investment, as its current market cap is...

Value Investors Club

Analyzing Active Portfolio Ideas: Antitrust, Asset Sales, Arbitrage, and Litigation Opportunities

VIZIO faces antitrust concerns with Walmart acquisition; FTC scrutiny and potential challenges could impact deal closure and stock price.

Special Situation Investments

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)